查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2081974

自動胰島素輸注系統市場：2026-2032年全球市場預測（按產品類型、組件、胰島素類型、技術、糖尿病類型、護理環境、最終用戶和分銷管道分類）

Automated Insulin Delivery System Market by Product Type, Component, Insulin Type, Technology, Diabetes Type, Care Setting, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，自動胰島素輸送 (AID) 系統市場將成長至 1,942,070,000 美元，複合年成長率為 10.09%。

主要市場統計數據
基準年 2025 9.9029億美元
預計年份：2026年 1,085,190,000 美元
預測年份：2032年 1,942,070,000 美元
複合年成長率 (%) 10.09%

自動胰島素輸注系統，通常也稱為混合閉合迴路系統或人工胰臟系統，結合了胰島素幫浦、持續血糖監測儀 (CGM)、輸注演算法和配套軟體，可根據即時血糖值趨勢調整胰島素劑量。隨著臨床證據、法規核准和保險公司認可的不斷提高，這一領域已從早期針對 1 型糖尿病的創新發展成為糖尿病治療的核心技術之一。

糖尿病給身體帶來日益沉重的負擔，這一現實催生了對智慧胰島素管理的需求。根據國際糖尿病聯盟（IDF）估計，2021年全球有5.37億成年人患有糖尿病，預計到2030年這一數字將達到6.43億，到2045年將達到7.83億。雖然智慧胰島素管理在第1型糖尿病領域應用最為廣泛，但隨著臨床醫生、保險公司和醫療設備開發商評估智慧胰島素管理能否降低低血糖風險、延長血糖值維持在目標範圍內的時間以及支持更安全的自我管理，人們對智慧胰島素管理的興趣也日益濃厚。

愛滋病領域的變革性變化

自動胰島素輸注領域正從以設備為中心的創新轉向一體化的糖尿病管理生態系統。競爭格局日益受到以下因素的影響：胰島素幫浦硬體、持續血糖監測（CGM）的互通性、演算法效能、行動應用程式的易用性、遠端監測、雲端分析、客戶支援、網路安全以及與臨床工作流程的資料整合。

人工智慧（AI）的累積影響

人工智慧正透過更個人化的治療、預測性決策支援和人群層面的分析，重塑自動胰島素輸注方式。目前市面上的自動胰島素輸注系統主要依賴控制演算法來調整基礎胰島素大劑量投藥。而下一代系統預計將更廣泛地應用機器學習技術，以識別與飲食、運動、壓力、疾病、睡眠和治療依從性相關的模式。

關鍵區域洞察

北美仍然是自動胰島素輸注技術最成熟的地區，其中美國發揮主導作用。在美國，FDA已通過核准的自動胰島素輸注系統、持續血糖監測（CGM）的高普及率、先進的內分泌網路以及公立和私立醫療保險的覆蓋，都在推動這項技術的普及。在加拿大，儘管目前實行的是省級主導的報銷模式，胰島素幫浦治療、CGM和混合閉合迴路系統的普及程度也不均衡，但情況正在改善。

關鍵小組洞察

在東協，自動胰島素輸注技術主要集中在新加坡、馬來西亞和泰國等市場的私人醫院和糖尿病診所。然而，要實現更廣泛的普及，需要擴大保險覆蓋範圍、建立糖尿病教育項目，並確保動態血糖監測儀（CGM）和輸注裝置的持續供應。海灣合作理事會（GCC）市場因其糖尿病高發、私營部門強大的購買力以及政府推行的數位化醫療計畫而極具吸引力。尤其是在沙烏地阿拉伯和阿拉伯聯合大公國，互聯醫療計畫正在支援遠端監測和專家主導的糖尿病管理。

主要國家概況

美國憑藉其獲得FDA已通過核准的系統、較高的動態血糖監測（CGM）普及率、完善的內分泌網路以及大量接受治療的1型糖尿病患者，在自動胰島素注射器的應用方面處於全球領先地位。加拿大的普及率也穩定上升，但各省的報銷方案不盡相同，影響了胰島素幫浦、動態血糖監測儀和耗材的取得。墨西哥和巴西是拉丁美洲市場的重要機遇，其私人保險支付管道、主要城市的內分泌中心以及人們對糖尿病相關技術的日益了解，都在推動公共報銷機制尚未廣泛建立之前，推動了相關技術的普及。

為行業領導者提供的實用建議

行業領導者應優先考慮互通性、為保險公司提供證據以及以患者為中心的設計。隨著糖尿病照護轉向互聯互通、以結果為導向的管理模式轉變，能夠減輕使用者負擔、支援多種動態血糖監測（CGM）方案、連接智慧型手機並提供安全遠端監測的系統將更具優勢。

調查方法

本調查方法基於三角檢驗法，採用二手研究，重點關注檢驗的資訊來源、臨床證據、監管資料庫以及與醫療保健系統相關的政策趨勢。主要參考文獻包括國際糖尿病聯盟 (IDF) 的糖尿病盛行率估計、美國疾病管制與預防中心 (CDC) 的糖尿病統計數據、美國醫療設備分類和核准流程、英國國家衛生與臨床最佳化研究所 (NICE) 的指南、美國糖尿病協會 (ADA) 的實踐標準、同儕審查的臨床試驗指南、公共保險指南

結論

自動胰島素輸注正逐漸成為現代胰島素依賴型糖尿病治療的關鍵技術。糖尿病盛行率的上升、強力的臨床證據表明其能改善血糖控制、持續血糖監測（CGM）的廣泛應用，以及法律規範對可互通數位醫療設備的日益認可，都推動了這一領域的發展。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 工業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 自動胰島素輸注系統市場：依產品類型分類

  • 完全封閉回路型
  • 混合封閉回路型
    • 模糊邏輯
    • 模型預測控制
    • 比例/積分/微分 (PID)
  • 帶感測器功能的泵
  • 具有閾值停止功能的胰島素泵

第8章 自動胰島素輸注系統市場：依組件分類

  • 持續血糖監測
    • 閃光監控
    • 即時的
  • 控制演算法軟體
    • 基於雲端的
    • 移動基地
  • 泵浦
    • 貼片幫浦
    • 管式幫浦

第9章：自動胰島素輸注系統市場：依胰島素類型分類

  • 快速起效
    • Aspart
    • Glulisine
    • Lispro
  • 常規 U100
  • 超速效型
    • 菲亞水療中心
    • 魯姆傑布

第10章：自動胰島素輸注系統市場：依技術分類

  • 藍牙相容
    • BLE 5.0
    • 傳統藍牙低功耗
  • 細胞基礎
  • 具備 Wi-Fi 功能
    • 2.4 GHz
    • 5 GHz5 GHz

第11章：自動胰島素輸注系統市場：依糖尿病類型分類

  • 沃
  • 1型
    • 早髮型
    • 遲發性自體免疫型
  • 類型 2
    • 胰島素依賴型
    • 胰島素非依賴性

第12章：自動胰島素輸注系統市場：依照護環境分類

  • 住院治療
    • 普通病房
    • 加護病房
  • 門診
    • 門診日間護理
    • 專科診所

第13章：自動胰島素輸注系統市場：依最終用戶分類

  • 門診
  • 診所
  • 居家醫療
    • 成人用戶
    • 兒童患者
  • 醫院
    • 門診手術中心
    • 住院治療

第14章：自動胰島素輸注系統市場：依通路分類

  • 物理藥房
  • 網路藥房

第15章 自動胰島素輸注系統市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第16章 自動胰島素輸注系統市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第17章 自動胰島素輸注系統市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第19章：公司簡介

  • Abbott Laboratories
  • Ascensia Diabetes Care Holdings AG
  • Becton, Dickinson and Company
  • Beta Bionics, Inc.
  • Bigfoot Biomedical, Inc.
  • CamDiab Limited
  • Cellnovo Group SA
  • Companion Medical, Inc.
  • Dexcom, Inc.
  • Diabeloop SA
  • DreaMed Diabetes Ltd.
  • Eli Lilly and Company
  • EOFlow Co., Ltd.
  • F. Hoffmann-La Roche Ltd
  • Glooko, Inc.
  • i-SENS, Inc.
  • Insulcloud SL
  • Insulet Corporation
  • Medtronic plc
  • Medtrum Technologies Inc.
  • MicroTech Medical（Hangzhou）Co., Ltd.
  • Novo Nordisk A/S
  • Pancreum, Inc.
  • Pendiq GmbH
  • Roche Diabetes Care GmbH
  • Sanofi SA
  • Senseonics Holdings, Inc.
  • Sequel Med Tech, LLC
  • Sinocare Inc.
  • SOOIL Development Co., Ltd.
  • Tandem Diabetes Care, Inc.
  • Tidepool Project
  • TypeZero Technologies, LLC
  • Valeritas Holdings, Inc.
  • Ypsomed Holding AG
Product Code: MRR-437517DB6E7D

The Automated Insulin Delivery System Market is projected to grow by USD 1,942.07 million at a CAGR of 10.09% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 990.29 million
Estimated Year [2026] USD 1,085.19 million
Forecast Year [2032] USD 1,942.07 million
CAGR (%) 10.09%

Automated insulin delivery systems, often described as hybrid closed-loop or artificial pancreas systems, combine an insulin pump, continuous glucose monitor (CGM), dosing algorithm, and connected software to adjust insulin delivery based on real-time glucose trends. The category has moved from early type 1 diabetes innovation to a core diabetes technology segment as clinical evidence, regulatory clearances, and payer recognition expand.

Demand is grounded in a large and rising diabetes burden. The International Diabetes Federation estimated that 537 million adults were living with diabetes in 2021 and projected 643 million by 2030 and 783 million by 2045. While automated insulin delivery is most established in type 1 diabetes, interest is widening as clinicians, payers, and device developers evaluate how connected insulin management can reduce hypoglycemia, improve time in range, and support safer self-management.

Transformative Shifts in the AID Landscape

The automated insulin delivery landscape is shifting from device-centric innovation to integrated diabetes management ecosystems. Competition is increasingly shaped not only by pump hardware, but also by CGM interoperability, algorithm performance, mobile app usability, remote monitoring, cloud analytics, customer support, cybersecurity, and data integration with clinical workflows.

Regulatory and reimbursement changes are accelerating adoption. The U.S. FDA's interoperable pathways for integrated CGMs, alternate controller enabled pumps, and automated glycemic controllers have encouraged modular system development, while broader CGM coverage in the United States has strengthened the installed base needed for AID uptake. In Europe, the transition to the Medical Device Regulation has raised evidence and post-market surveillance expectations, and the United Kingdom's NICE recommendation for hybrid closed-loop systems in type 1 diabetes has reinforced the value case for clinically appropriate patients.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is reshaping automated insulin delivery through better personalization, predictive decision support, and population-level analytics. Current commercial AID systems rely on control algorithms that adjust basal insulin and, in some platforms, deliver correction boluses; the next wave is expected to use machine learning more extensively to identify patterns related to meals, exercise, stress, illness, sleep, and adherence.

The cumulative impact of AI will depend on evidence quality and safety governance. FDA guidance on predetermined change control plans for AI-enabled medical devices signals a pathway for controlled algorithm updates, but manufacturers must prove that adaptive features improve outcomes without increasing hypoglycemia risk. AI can also support customer service triage, device failure prediction, clinician dashboards, and behavioral coaching, creating value beyond the dosing algorithm itself.

Key Regional Insights

North America remains the most mature region for automated insulin delivery, led by the United States, where FDA-cleared AID systems, high CGM use, advanced endocrinology networks, and commercial as well as public payer coverage support adoption. Canada follows a more province-driven reimbursement model, creating uneven but improving access for insulin pump therapy, CGMs, and hybrid closed-loop systems.

Europe is a major clinical and regulatory market, with Germany, France, Italy, Spain, and the United Kingdom shaping adoption through national health systems, health technology assessment reviews, diabetes registries, and CE-marked device availability. The region's Medical Device Regulation has increased expectations for clinical evidence, post-market surveillance, software validation, and data protection, making compliance strength a central differentiator.

Asia-Pacific is the fastest-developing opportunity as China, Japan, India, South Korea, and Australia combine large diabetes populations with expanding digital health infrastructure. Japan, South Korea, and Australia benefit from advanced specialist care and stronger CGM familiarity, while China and India present broad unmet need but face affordability, reimbursement, and diabetes educator capacity constraints. Latin America, the Middle East, and Africa show rising demand in private care and urban diabetes centers; however, reimbursement gaps, supply continuity, clinician training, and uneven access to sensors and infusion consumables limit broader use.

Key Group Insights

Within ASEAN, automated insulin delivery adoption is concentrated in private hospitals and specialist diabetes clinics in markets such as Singapore, Malaysia, and Thailand, while broader access depends on reimbursement expansion, diabetes educator capacity, and continuity of CGM and infusion set supply. GCC countries are attractive due to high diabetes prevalence, strong private-sector purchasing, and government digital health programs, particularly in Saudi Arabia and the United Arab Emirates, where connected care initiatives support remote monitoring and specialist-led diabetes management.

The European Union offers scale through harmonized CE-mark access, but country-level reimbursement and health technology assessment decisions still determine uptake. BRICS markets present significant long-term adoption potential because of population size, rising diabetes diagnosis, and increasing CGM awareness, although local pricing, distribution, regulatory approvals, and domestic manufacturing strategies are decisive. G7 countries remain the highest-value commercialization group because of advanced clinical guidelines, mature device regulation, established payer capacity, and stronger real-world evidence infrastructure. NATO markets overlap significantly with Europe and North America and increasingly emphasize procurement resilience, cybersecurity, data privacy, and supply-chain reliability for connected medical devices.

Key Country Insights

The United States is the global adoption leader for automated insulin delivery, supported by FDA-cleared systems, strong CGM use, established endocrinology networks, and a large treated type 1 diabetes population. Canada shows steady uptake, but reimbursement varies by province and affects access to pumps, CGMs, and consumables. Mexico and Brazil represent important Latin American opportunities where private-pay channels, major urban endocrinology centers, and growing awareness of diabetes technology lead adoption before broader public reimbursement develops.

In Europe, the United Kingdom is positioned for faster public-sector scale following NICE guidance for hybrid closed-loop use in type 1 diabetes, while Germany, France, Italy, and Spain are shaped by national reimbursement processes, hospital-led diabetes technology programs, and clinician training capacity. Russia remains more limited by regulatory, import, supply-chain, and reimbursement conditions, which can restrict access to advanced connected diabetes devices.

China offers large long-term potential due to population scale, rising diabetes diagnosis, digital health adoption, and domestic medtech investment, while India combines substantial unmet need with affordability challenges and uneven specialist access. Japan, South Korea, and Australia have advanced clinical infrastructures and strong CGM familiarity, making them important countries for premium systems, pediatric use, remote monitoring, and real-world evidence generation.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize interoperability, payer evidence, and patient-centered design. Systems that reduce user burden, support multiple CGM options, integrate with smartphones, and provide secure remote monitoring are better positioned as diabetes care shifts toward connected, outcomes-based management.

Manufacturers should invest in real-world evidence that demonstrates time-in-range improvement, hypoglycemia reduction, quality-of-life gains, and health-economic value. Commercial strategies should segment countries by reimbursement maturity, develop clinician and diabetes educator training programs, localize onboarding support, and build resilient supply chains for sensors, infusion sets, reservoirs, batteries, software updates, and replacement devices.

Research Methodology

Research methodology is developed using a secondary and triangulated research approach focused on verified public sources, clinical evidence, regulatory databases, and health-system policy signals. Key reference categories include International Diabetes Federation diabetes prevalence estimates, U.S. CDC diabetes statistics, FDA device classification and clearance pathways, NICE guidance, ADA Standards of Care, peer-reviewed trials, regulatory notices, reimbursement policies, and public clinical practice guidance.

Market interpretation is built by comparing disease burden, CGM penetration, reimbursement maturity, regulatory readiness, clinical infrastructure, diabetes educator availability, digital health adoption, cybersecurity expectations, and supply-chain conditions across regions and countries. Insights are validated through consistency checks across clinical outcomes, payer policy, device availability, regulatory pathways, and adoption barriers rather than relying on a single indicator.

Conclusion

Automated insulin delivery is becoming a defining technology in modern insulin-dependent diabetes care. The sector is supported by rising diabetes prevalence, strong clinical evidence for improved glycemic control, expanding CGM use, and regulatory frameworks that increasingly recognize interoperable digital medical devices.

The next phase of adoption will be determined by affordability, reimbursement, AI-enabled personalization, cybersecurity, supply continuity, clinical training, and ease of use. Organizations that combine clinically proven algorithms with patient-friendly design, scalable support models, interoperable platforms, and robust real-world evidence will be best positioned to advance the global automated insulin delivery ecosystem.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Automated Insulin Delivery System Market, by Product Type

  • 7.1. Fully Closed Loop
  • 7.2. Hybrid Closed Loop
    • 7.2.1. Fuzzy Logic
    • 7.2.2. Model Predictive Control
    • 7.2.3. Proportional Integral Derivative
  • 7.3. Sensor Augmented Pump
  • 7.4. Threshold Suspend Pump

8. Automated Insulin Delivery System Market, by Component

  • 8.1. Continuous Glucose Monitor
    • 8.1.1. Flash Monitoring
    • 8.1.2. Real Time
  • 8.2. Control Algorithm Software
    • 8.2.1. Cloud Based
    • 8.2.2. Mobile Based
  • 8.3. Pump
    • 8.3.1. Patch Pump
    • 8.3.2. Tubed Pump

9. Automated Insulin Delivery System Market, by Insulin Type

  • 9.1. Rapid Acting
    • 9.1.1. Aspart
    • 9.1.2. Glulisine
    • 9.1.3. Lispro
  • 9.2. Regular U100
  • 9.3. Ultra Rapid
    • 9.3.1. Fiasp
    • 9.3.2. Lyumjev

10. Automated Insulin Delivery System Market, by Technology

  • 10.1. Bluetooth Based
    • 10.1.1. BLE 5.0
    • 10.1.2. Legacy BLE
  • 10.2. Cellular Based
  • 10.3. WiFi Based
    • 10.3.1. 2.4 GHz
    • 10.3.2. 5 GHz

11. Automated Insulin Delivery System Market, by Diabetes Type

  • 11.1. Gestational
  • 11.2. Type 1
    • 11.2.1. Juvenile Onset
    • 11.2.2. Late Autoimmune
  • 11.3. Type 2
    • 11.3.1. Insulin Dependent
    • 11.3.2. Non Insulin Dependent

12. Automated Insulin Delivery System Market, by Care Setting

  • 12.1. Inpatient
    • 12.1.1. General Ward
    • 12.1.2. Intensive Care Unit
  • 12.2. Outpatient
    • 12.2.1. Ambulatory Daycare
    • 12.2.2. Specialty Clinic

13. Automated Insulin Delivery System Market, by End User

  • 13.1. Ambulatory
  • 13.2. Clinics
  • 13.3. Homecare
    • 13.3.1. Adult Users
    • 13.3.2. Pediatric Users
  • 13.4. Hospital
    • 13.4.1. Ambulatory Surgical Centers
    • 13.4.2. Inpatient

14. Automated Insulin Delivery System Market, by Distribution Channel

  • 14.1. Offline Pharmacy
  • 14.2. Online Pharmacy

15. Automated Insulin Delivery System Market, by Region

  • 15.1. Asia-Pacific
  • 15.2. North America
  • 15.3. Latin America
  • 15.4. Europe
  • 15.5. Middle East
  • 15.6. Africa

16. Automated Insulin Delivery System Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Automated Insulin Delivery System Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025

19. Company Profiles

  • 19.1. Abbott Laboratories
  • 19.2. Ascensia Diabetes Care Holdings AG
  • 19.3. Becton, Dickinson and Company
  • 19.4. Beta Bionics, Inc.
  • 19.5. Bigfoot Biomedical, Inc.
  • 19.6. CamDiab Limited
  • 19.7. Cellnovo Group S.A.
  • 19.8. Companion Medical, Inc.
  • 19.9. Dexcom, Inc.
  • 19.10. Diabeloop S.A.
  • 19.11. DreaMed Diabetes Ltd.
  • 19.12. Eli Lilly and Company
  • 19.13. EOFlow Co., Ltd.
  • 19.14. F. Hoffmann-La Roche Ltd
  • 19.15. Glooko, Inc.
  • 19.16. i-SENS, Inc.
  • 19.17. Insulcloud S.L.
  • 19.18. Insulet Corporation
  • 19.19. Medtronic plc
  • 19.20. Medtrum Technologies Inc.
  • 19.21. MicroTech Medical (Hangzhou) Co., Ltd.
  • 19.22. Novo Nordisk A/S
  • 19.23. Pancreum, Inc.
  • 19.24. Pendiq GmbH
  • 19.25. Roche Diabetes Care GmbH
  • 19.26. Sanofi S.A.
  • 19.27. Senseonics Holdings, Inc.
  • 19.28. Sequel Med Tech, LLC
  • 19.29. Sinocare Inc.
  • 19.30. SOOIL Development Co., Ltd.
  • 19.31. Tandem Diabetes Care, Inc.
  • 19.32. Tidepool Project
  • 19.33. TypeZero Technologies, LLC
  • 19.34. Valeritas Holdings, Inc.
  • 19.35. Ypsomed Holding AG

LIST OF FIGURES

  • FIGURE 1. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY COMPONENT, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY INSULIN TYPE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY INSULIN TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DIABETES TYPE, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DIABETES TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY CARE SETTING, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY CARE SETTING, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 27. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 29. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL FULLY CLOSED LOOP MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL FULLY CLOSED LOOP MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL FULLY CLOSED LOOP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL HYBRID CLOSED LOOP MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL HYBRID CLOSED LOOP MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL HYBRID CLOSED LOOP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL FUZZY LOGIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL FUZZY LOGIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL FUZZY LOGIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MODEL PREDICTIVE CONTROL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MODEL PREDICTIVE CONTROL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MODEL PREDICTIVE CONTROL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PROPORTIONAL INTEGRAL DERIVATIVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PROPORTIONAL INTEGRAL DERIVATIVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PROPORTIONAL INTEGRAL DERIVATIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SENSOR AUGMENTED PUMP MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL SENSOR AUGMENTED PUMP MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL SENSOR AUGMENTED PUMP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL THRESHOLD SUSPEND PUMP MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL THRESHOLD SUSPEND PUMP MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL THRESHOLD SUSPEND PUMP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CONTINUOUS GLUCOSE MONITOR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CONTINUOUS GLUCOSE MONITOR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CONTINUOUS GLUCOSE MONITOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL FLASH MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL FLASH MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL FLASH MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL REAL TIME MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL REAL TIME MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL REAL TIME MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CONTROL ALGORITHM SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CONTROL ALGORITHM SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CONTROL ALGORITHM SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CLOUD BASED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CLOUD BASED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CLOUD BASED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MOBILE BASED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MOBILE BASED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MOBILE BASED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PUMP MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PUMP MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PUMP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PATCH PUMP MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PATCH PUMP MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PATCH PUMP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL TUBED PUMP MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL TUBED PUMP MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL TUBED PUMP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL RAPID ACTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL RAPID ACTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL RAPID ACTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ASPART MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ASPART MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ASPART MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL GLULISINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL GLULISINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL GLULISINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL LISPRO MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL LISPRO MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL LISPRO MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL REGULAR U100 MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL REGULAR U100 MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL REGULAR U100 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ULTRA RAPID MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ULTRA RAPID MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ULTRA RAPID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL FIASP MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL FIASP MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL FIASP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL LYUMJEV MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL LYUMJEV MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL LYUMJEV MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL BLUETOOTH BASED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL BLUETOOTH BASED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL BLUETOOTH BASED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL BLE 5.0 MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL BLE 5.0 MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL BLE 5.0 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL LEGACY BLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL LEGACY BLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL LEGACY BLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL CELLULAR BASED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL CELLULAR BASED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL CELLULAR BASED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL WIFI BASED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL WIFI BASED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL WIFI BASED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL 2.4 GHZ MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL 2.4 GHZ MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL 2.4 GHZ MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL 5 GHZ MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL 5 GHZ MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL 5 GHZ MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DIABETES TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL GESTATIONAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL GESTATIONAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL GESTATIONAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL TYPE 1 MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL TYPE 1 MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL TYPE 1 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL JUVENILE ONSET MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL JUVENILE ONSET MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL JUVENILE ONSET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL LATE AUTOIMMUNE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL LATE AUTOIMMUNE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL LATE AUTOIMMUNE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL TYPE 2 MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL TYPE 2 MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL TYPE 2 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL INSULIN DEPENDENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL INSULIN DEPENDENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL INSULIN DEPENDENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL NON INSULIN DEPENDENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL NON INSULIN DEPENDENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL NON INSULIN DEPENDENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY CARE SETTING, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL INPATIENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL INPATIENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL INPATIENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL GENERAL WARD MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL GENERAL WARD MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL GENERAL WARD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL INTENSIVE CARE UNIT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL INTENSIVE CARE UNIT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL INTENSIVE CARE UNIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL OUTPATIENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL OUTPATIENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL OUTPATIENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL AMBULATORY DAYCARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL AMBULATORY DAYCARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL AMBULATORY DAYCARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL SPECIALTY CLINIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL SPECIALTY CLINIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL SPECIALTY CLINIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL AMBULATORY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL AMBULATORY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL AMBULATORY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL HOMECARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL HOMECARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL HOMECARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL ADULT USERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL ADULT USERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL ADULT USERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL PEDIATRIC USERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL PEDIATRIC USERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL PEDIATRIC USERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL HOSPITAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL HOSPITAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL HOSPITAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL INPATIENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 163. GLOBAL INPATIENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL INPATIENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL OFFLINE PHARMACY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL OFFLINE PHARMACY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL OFFLINE PHARMACY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. GLOBAL ONLINE PHARMACY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL ONLINE PHARMACY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL ONLINE PHARMACY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY HYBRID CLOSED LOOP, 2018-2032 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY CONTINUOUS GLUCOSE MONITOR, 2018-2032 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY CONTROL ALGORITHM SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 179. ASIA-PACIFIC AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY PUMP, 2018-2032 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY RAPID ACTING, 2018-2032 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY ULTRA RAPID, 2018-2032 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY BLUETOOTH BASED, 2018-2032 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY WIFI BASED, 2018-2032 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DIABETES TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY TYPE 1, 2018-2032 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY TYPE 2, 2018-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY CARE SETTING, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY INPATIENT, 2018-2032 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY OUTPATIENT, 2018-2032 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY HOMECARE, 2018-2032 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 196. NORTH AMERICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 197. NORTH AMERICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. NORTH AMERICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY HYBRID CLOSED LOOP, 2018-2032 (USD MILLION)
  • TABLE 199. NORTH AMERICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 200. NORTH AMERICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY CONTINUOUS GLUCOSE MONITOR, 2018-2032 (USD MILLION)
  • TABLE 201. NORTH AMERICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY CONTROL ALGORITHM SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 202. NORTH AMERICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY PUMP, 2018-2032 (USD MILLION)
  • TABLE 203. NORTH AMERICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. NORTH AMERICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY RAPID ACTING, 2018-2032 (USD MILLION)
  • TABLE 205. NORTH AMERICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY ULTRA RAPID, 2018-2032 (USD MILLION)
  • TABLE 206. NORTH AMERICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 207. NORTH AMERICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY BLUETOOTH BASED, 2018-2032 (USD MILLION)
  • TABLE 208. NORTH AMERICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY WIFI BASED, 2018-2032 (USD MILLION)
  • TABLE 209. NORTH AMERICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DIABETES TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. NORTH AMERICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY TYPE 1, 2018-2032 (USD MILLION)
  • TABLE 211. NORTH AMERICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY TYPE 2, 2018-2032 (USD MILLION)
  • TABLE 212. NORTH AMERICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY CARE SETTING, 2018-2032 (USD MILLION)
  • TABLE 213. NORTH AMERICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY INPATIENT, 2018-2032 (USD MILLION)
  • TABLE 214. NORTH AMERICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY OUTPATIENT, 2018-2032 (USD MILLION)
  • TABLE 215. NORTH AMERICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 216. NORTH AMERICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY HOMECARE, 2018-2032 (USD MILLION)
  • TABLE 217. NORTH AMERICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 218. NORTH AMERICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 219. LATIN AMERICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 220. LATIN AMERICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. LATIN AMERICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY HYBRID CLOSED LOOP, 2018-2032 (USD MILLION)
  • TABLE 222. LATIN AMERICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 223. LATIN AMERICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY CONTINUOUS GLUCOSE MONITOR, 2018-2032 (USD MILLION)
  • TABLE 224. LATIN AMERICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY CONTROL ALGORITHM SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 225. LATIN AMERICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY PUMP, 2018-2032 (USD MILLION)
  • TABLE 226. LATIN AMERICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. LATIN AMERICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY RAPID ACTING, 2018-2032 (USD MILLION)
  • TABLE 228. LATIN AMERICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY ULTRA RAPID, 2018-2032 (USD MILLION)
  • TABLE 229. LATIN AMERICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 230. LATIN AMERICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY BLUETOOTH BASED, 2018-2032 (USD MILLION)
  • TABLE 231. LATIN AMERICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY WIFI BASED, 2018-2032 (USD MILLION)
  • TABLE 232. LATIN AMERICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DIABETES TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. LATIN AMERICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY TYPE 1, 2018-2032 (USD MILLION)
  • TABLE 234. LATIN AMERICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY TYPE 2, 2018-2032 (USD MILLION)
  • TABLE 235. LATIN AMERICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY CARE SETTING, 2018-2032 (USD MILLION)
  • TABLE 236. LATIN AMERICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY INPATIENT, 2018-2032 (USD MILLION)
  • TABLE 237. LATIN AMERICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY OUTPATIENT, 2018-2032 (USD MILLION)
  • TABLE 238. LATIN AMERICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 239. LATIN AMERICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY HOMECARE, 2018-2032 (USD MILLION)
  • TABLE 240. LATIN AMERICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 241. LATIN AMERICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPE AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 243. EUROPE AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 244. EUROPE AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY HYBRID CLOSED LOOP, 2018-2032 (USD MILLION)
  • TABLE 245. EUROPE AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 246. EUROPE AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY CONTINUOUS GLUCOSE MONITOR, 2018-2032 (USD MILLION)
  • TABLE 247. EUROPE AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY CONTROL ALGORITHM SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 248. EUROPE AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY PUMP, 2018-2032 (USD MILLION)
  • TABLE 249. EUROPE AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 250. EUROPE AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY RAPID ACTING, 2018-2032 (USD MILLION)
  • TABLE 251. EUROPE AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY ULTRA RAPID, 2018-2032 (USD MILLION)
  • TABLE 252. EUROPE AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 253. EUROPE AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY BLUETOOTH BASED, 2018-2032 (USD MILLION)
  • TABLE 254. EUROPE AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY WIFI BASED, 2018-2032 (USD MILLION)
  • TABLE 255. EUROPE AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DIABETES TYPE, 2018-2032 (USD MILLION)
  • TABLE 256. EUROPE AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY TYPE 1, 2018-2032 (USD MILLION)
  • TABLE 257. EUROPE AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY TYPE 2, 2018-2032 (USD MILLION)
  • TABLE 258. EUROPE AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY CARE SETTING, 2018-2032 (USD MILLION)
  • TABLE 259. EUROPE AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY INPATIENT, 2018-2032 (USD MILLION)
  • TABLE 260. EUROPE AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY OUTPATIENT, 2018-2032 (USD MILLION)
  • TABLE 261. EUROPE AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 262. EUROPE AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY HOMECARE, 2018-2032 (USD MILLION)
  • TABLE 263. EUROPE AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 264. EUROPE AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 265. MIDDLE EAST AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 266. MIDDLE EAST AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 267. MIDDLE EAST AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY HYBRID CLOSED LOOP, 2018-2032 (USD MILLION)
  • TABLE 268. MIDDLE EAST AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 269. MIDDLE EAST AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY CONTINUOUS GLUCOSE MONITOR, 2018-2032 (USD MILLION)
  • TABLE 270. MIDDLE EAST AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY CONTROL ALGORITHM SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 271. MIDDLE EAST AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY PUMP, 2018-2032 (USD MILLION)
  • TABLE 272. MIDDLE EAST AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 273. MIDDLE EAST AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY RAPID ACTING, 2018-2032 (USD MILLION)
  • TABLE 274. MIDDLE EAST AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY ULTRA RAPID, 2018-2032 (USD MILLION)
  • TABLE 275. MIDDLE EAST AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 276. MIDDLE EAST AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY BLUETOOTH BASED, 2018-2032 (USD MILLION)
  • TABLE 277. MIDDLE EAST AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY WIFI BASED, 2018-2032 (USD MILLION)
  • TABLE 278. MIDDLE EAST AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DIABETES TYPE, 2018-2032 (USD MILLION)
  • TABLE 279. MIDDLE EAST AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY TYPE 1, 2018-2032 (USD MILLION)
  • TABLE 280. MIDDLE EAST AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY TYPE 2, 2018-2032 (USD MILLION)
  • TABLE 281. MIDDLE EAST AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY CARE SETTING, 2018-2032 (USD MILLION)
  • TABLE 282. MIDDLE EAST AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY INPATIENT, 2018-2032 (USD MILLION)
  • TABLE 283. MIDDLE EAST AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY OUTPATIENT, 2018-2032 (USD MILLION)
  • TABLE 284. MIDDLE EAST AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 285. MIDDLE EAST AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY HOMECARE, 2018-2032 (USD MILLION)
  • TABLE 286. MIDDLE EAST AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 287. MIDDLE EAST AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 288. AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 289. AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 290. AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY HYBRID CLOSED LOOP, 2018-2032 (USD MILLION)
  • TABLE 291. AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 292. AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY CONTINUOUS GLUCOSE MONITOR, 2018-2032 (USD MILLION)
  • TABLE 293. AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY CONTROL ALGORITHM SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 294. AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY PUMP, 2018-2032 (USD MILLION)
  • TABLE 295. AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 296. AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY RAPID ACTING, 2018-2032 (USD MILLION)
  • TABLE 297. AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY ULTRA RAPID, 2018-2032 (USD MILLION)
  • TABLE 298. AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 299. AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY BLUETOOTH BASED, 2018-2032 (USD MILLION)
  • TABLE 300. AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY WIFI BASED, 2018-2032 (USD MILLION)
  • TABLE 301. AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DIABETES TYPE, 2018-2032 (USD MILLION)
  • TABLE 302. AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY TYPE 1, 2018-2032 (USD MILLION)
  • TABLE 303. AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY TYPE 2, 2018-2032 (USD MILLION)
  • TABLE 304. AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY CARE SETTING, 2018-2032 (USD MILLION)
  • TABLE 305. AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY INPATIENT, 2018-2032 (USD MILLION)
  • TABLE 306. AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY OUTPATIENT, 2018-2032 (USD MILLION)
  • TABLE 307. AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 308. AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY HOMECARE, 2018-2032 (USD MILLION)
  • TABLE 309. AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 310. AFRICA AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 311. GLOBAL AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 312. ASEAN AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 313. ASEAN AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 314. ASEAN AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY HYBRID CLOSED LOOP, 2018-2032 (USD MILLION)
  • TABLE 315. ASEAN AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 316. ASEAN AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY CONTINUOUS GLUCOSE MONITOR, 2018-2032 (USD MILLION)
  • TABLE 317. ASEAN AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY CONTROL ALGORITHM SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 318. ASEAN AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY PUMP, 2018-2032 (USD MILLION)
  • TABLE 319. ASEAN AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 320. ASEAN AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY RAPID ACTING, 2018-2032 (USD MILLION)
  • TABLE 321. ASEAN AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY ULTRA RAPID, 2018-2032 (USD MILLION)
  • TABLE 322. ASEAN AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 323. ASEAN AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY BLUETOOTH BASED, 2018-2032 (USD MILLION)
  • TABLE 324. ASEAN AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY WIFI BASED, 2018-2032 (USD MILLION)
  • TABLE 325. ASEAN AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DIABETES TYPE, 2018-2032 (USD MILLION)
  • TABLE 326. ASEAN AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY TYPE 1, 2018-2032 (USD MILLION)
  • TABLE 327. ASEAN AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY TYPE 2, 2018-2032 (USD MILLION)
  • TABLE 328. ASEAN AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY CARE SETTING, 2018-2032 (USD MILLION)
  • TABLE 329. ASEAN AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY INPATIENT, 2018-2032 (USD MILLION)
  • TABLE 330. ASEAN AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY OUTPATIENT, 2018-2032 (USD MILLION)
  • TABLE 331. ASEAN AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 332. ASEAN AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY HOMECARE, 2018-2032 (USD MILLION)
  • TABLE 333. ASEAN AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 334. ASEAN AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 335. GCC AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 336. GCC AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 337. GCC AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY HYBRID CLOSED LOOP, 2018-2032 (USD MILLION)
  • TABLE 338. GCC AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 339. GCC AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY CONTINUOUS GLUCOSE MONITOR, 2018-2032 (USD MILLION)
  • TABLE 340. GCC AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY CONTROL ALGORITHM SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 341. GCC AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY PUMP, 2018-2032 (USD MILLION)
  • TABLE 342. GCC AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 343. GCC AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY RAPID ACTING, 2018-2032 (USD MILLION)
  • TABLE 344. GCC AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY ULTRA RAPID, 2018-2032 (USD MILLION)
  • TABLE 345. GCC AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 346. GCC AUTOMATED INSULIN DELIVERY SYSTEM MARKET SIZE, BY BLUETOOTH BASED, 2018-2032 (USD MILLION)
  • TABLE 347. GCC AUTOM